Trial
NCT04209179
A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Chugai Pharmaceutical
Collaborators
—
Condition
Hypoparathyroidism
Intervention
PCO371
Why stopped
Terminated on the basis of the currently uncertain risk-benefit balance for the patients, and the strategic position of the development program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-11